✦ LIBER ✦

Cutaneous melanoma in patients with sarcoma

✍ Scribed by Carola Berking; Mary S. Brady

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 105 KB
Volume: 79
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19970215)79:4<843::aid-cncr22>3.0.co;2-z

No coin nor oath required. For personal study only.

✦ Synopsis

melanoma and sarcoma when they reviewed their experience with other malignancies occurring in patients with a diagnosis of sarcoma. 1 Medical Student, Ludwig-Maximilians-Univer-

METHODS.

The authors identified 48 patients with both melanoma and bone or sity, Munich, Germany.

soft tissue sarcoma (STS) by a computer search of all sarcoma patients entered into their institution's cancer registry between 1943 and 1996 who had an additional

📜 SIMILAR VOLUMES

Sentinel node biopsy in patients with cu

Sentinel node biopsy in patients with cutaneous melanoma

✍ Ferdinando Cafiero; Alberto Peressini; Marco Gipponi; Maria Luisa Rainero; Giuse 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 28 KB

The role of elective lymph node dissection (ELND) for treatment of cutaneous melanoma is still debated. Initially, lymphatic mapping technique was performed by an intradermic injection of vital blue dye; subsequently, it was improved by the use of radioguided surgery (RGS). Preliminary experience wi

Second primary tumors in patients with c

Second primary tumors in patients with cutaneous malignant melanoma

✍ Smita Bhatia; Lilian Estrada-Batres; Tamara Maryon; Monica Bogue; David Chu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

Several studies report coexistent or subsequent primary tumors (SPT) among patients with malignant melanoma (MM), with the rate of incidence ranging from 1.5-20% depending on the sample size and the length and completeness of follow-up. ## METHODS. The authors followed a cohort of patients with c

Protein profiles in sera of patients wit

Protein profiles in sera of patients with malignant cutaneous melanoma

✍ Lorenza Ferrari; Roberta Seraglia; Carlo Riccardo Rossi; Antonella Bertazzo; Mar 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

Bans: A cutaneous region with no prognos

Bans: A cutaneous region with no prognostic significance in patients with melanoma

✍ Natale Cascinelli; Maurizio Vaglini; Rosaria Bufalino; Alberto Morabito 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

Cancer risk in patients with earlier dia

Cancer risk in patients with earlier diagnosis of cutaneous melanoma In situ

✍ Cecilia Wassberg; Magnus Thörn; Jonathan Yuen; Timo Hakulinen; Ulrik Ringborg 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 92 KB 👁 1 views

We calculated the short-term and long-term risks of developing cancer among 3,766 patients with a diagnosis of cutaneous melanoma in situ in Sweden from 1958 to 1992. In total, 393 patients developed a primary cancer at any site compared with an expected number of 177 [standardized incidence ratio (

Melanoma and soft tissue sarcoma in seve

Melanoma and soft tissue sarcoma in seven patients

✍ Judy E. Garber; Marcia K. Liepman; Ellen J. Gelles; Joseph M. Corson; Karen H. A 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Seven patients with both melanoma and sarcoma were seen at the Dana Farber Cancer Institute (Boston, MA) over a 4-year period. Three had additional malignant neoplasms; one of these patients also had the hereditary cutaneous malignant melanoma, dysplastic nevus syndrome. These observations suggest t